Oxonica Share Discussion Threads

[cootuk] 09/4/2007 14:46

Perhaps neuftec couldn't commercilaise it but, if you dont hold the patents or a long license, then you are stuffed.

[dieseltaylor] 09/4/2007 12:10

The Times article is mainly ballocks, rather disappointing really:

1. Share price has gone up from 115p to 135p since the 29th March - so what 12% fall

2. Neuftec licenses to Oxonica to use its technology and is mentioned 6 times in the admission document - a fact that completely escapes the reporter - it seems to imply they do not know each other!

3. Mr Matthews misquoted?

No mention of launch 17th April - better not to bias a good story.

[waldron] 09/4/2007 06:47

From The TimesApril 9, 2007

Double blow for UK nanotech companyJames Doran in New York
The future of one of Britain's leading nanotechnology companies is in doubt amid a legal battle over one of its key products and the near-collapse of its biggest contract with a national oil and gas company.

Oxonica, a technology company listed on the Alternative Investment Market (AIM), makes Envirox - a product designed to boost the efficiency of diesel fuel. Envirox is used in the fleet of buses operated by Stagecoach, the British national bus company, which also owns two million shares in Oxonica. The nanotechnology company is also one of the stable backed by Richard Farleigh, the Australian businessman and star of BBC2's Dragon's Den.

It has emerged that Envirox is at the centre of a legal dispute between Oxonica and Neuftec, a company based in the Dominican Republic that claims to have invented the fuel additive. Oxonica has filed a patents suit in London's High Court to protect itself against the claims. Neuftec has said that it will fight the suit and believes that the British firm is using its technology unlawfully.

Envirox, while just one of Oxonica's growing stable of nanotechnology products, is its most significant revenue driver.

Kevin Matthews, the chief executive of Oxonica, told The Times that the dispute with Neuftec was minor. "Intellectual property disputes like this are commonplace in nanotechnology," he said. But he urged Neuftec to come to the negotiating table.

Ronen Hazarika, the founder of Neuftec, said that any settlement would have to be substantial.

To compound the problems with Neuftec, Oxonica also faces losing its biggest Envirox contract - a deal worth more than $12 million (£6.1 million) from Petrol Ofisi, the Turkish national oil and gas company. Oxonica signed the Ofisi deal last year, which sent annual revenues soaring from £1.2 million to more than £10 million.

Last week Oxonica's shares fell more than 12 per cent on the AIM as it revealed that tests using Envirox in diesel engines in Turkey were disappointing. Oxonica claimed at the time that further tests had to be run, but Mr Matthews told The Times that the future of the Turkish deal looked bleak.

[colonel rigger] 31/3/2007 13:30

Reason share price has moved is article in this weeks Shares magazine as a buy on page 16

[matt7777] 29/3/2007 15:53

interesting price moves today - looks like buyers all day - perhaps mm's been filling big sells behind the scenes + been taking the mkt down

looks to be turning now though - offer price moving up !!

[cootuk] 28/3/2007 19:59

afaik high sulphur in diesel should generally give lower performance than low sulphur as the extra sulphur dioxide/trioxide can attack the exhaust sensors and also coat the catalyst on the catalytic conveter. There can also be a higher build up of deposits in any particulate trap that is fitted.
The cerium oxide should help provide a lower temperature burn off of foulants so I would have thought an improvement would have been seen.
Perhaps, as previously suggested, they need to use a stronger mix?

I would have thought they would have performed lab tests with high sulphur diesel to see the effect of dosing levels before deploying it as they were expecting around 1-1.5% as being in range of estimates. If they were expecting only a 1-1.5% improvement for high sulphur diesel then this definitely isn't as good as the 10% improvement we see with low sulphur diesel.

[matt7777] 28/3/2007 19:12

Management certainly making the point about high vs low sulphur - and that "extensive" trials using the higher grade stuff found across most of europe, the US and Asia shows much better fuel consumption improvements (5-11%). Not good news as this trial was supposed to show the rest of the oilcos the kind of improvement using Envirox could deliver... the results statement last week did mention supplier agreements in germany and italy though, so these may deliver better results. The supplier contract with Stagecoach is continuing in the UK and is giving an 8% pickup (from memory).

Not sure what this does to the SOP, Envirox is the main provider of cashflow at the moment, if, in the worst case it were dropped there could be some problems although Optisol (in 2008) and the nanoplex revenues should kick in fairly soon after that. Am v interested to find out about the exciting news on Apr 19... will definitely hold on to my position until then, and will add if this gets silly...

[dieseltaylor] 28/3/2007 11:46

Agreed the news is not good however my betting is something to do with the diesel formulation and possibly a higher grade of diesel was needed. Wild guessing on my part as I am not a fuel expert but the reference to low-sulphur might be pointing us that way.

AS for the sop for the future I draw comfort from the guess it must be a pretty big sop otherwise the backlash could be killing if it is a damp squib. The Directors must understand that they cannot announce a "key development" unless it is truly important - still I could be wrong on that. :)

[pugugly] 28/3/2007 11:09

News from turkey does not sound good at all, especially given the revenue from trukey last year. Any technical experts on this board any idea what could be giving this poor level of performance -v- the UK results?

The "jam tomorrow" news to be announced seems to me to be an attempt to mitigate the poor news.

Staying on the side.

[waldron] 28/3/2007 09:03

Oxonica says second data point from Envirox trial in Turkey 'inconclusive'


LONDON (AFX) - Oxonica PLC said the initial results from the second data
point of 30,000 km of the fuel-borne nanocatalyst Envirox track trial -- being
carried out in Turkey on Turkish high-sulphur diesel fuel -- are currently
"inconclusive".
This follows the positive results of a 1-1.5 pct fuel saving in the initial
data point of 20,000 km, which was in the range of management expectations at
that stage, the AIM-listed nanomaterials group said.
The company said despite the inconclusive second data point from the trial,
it believes "there is a large body of evidence" to support the view that Envirox
works effectively in a wide-range of operating conditions to reduce fuel
consumption and emissions.
Meanwhile, the group's activities in healthcare, security and materials
sectors are making good progress, and a key technology development in healthcare
is expected to be announced on April 19.

[e-mail]
tsk/am

[waldron] 28/3/2007 08:04

Oxonica Statement re Track Trial


RNS Number:8596T
Oxonica plc
28 March 2007




28 March 2007


Oxonica plc


Initial Results from ENVIROX(TM) Track Trial in Turkey


Oxonica plc ("Oxonica") a leading international nanomaterials group, today
announces that it has received the initial results from the second data point
(30,000 km) of the ENVIROX(TM) track trial being carried out in Turkey on
Turkish, high-sulphur diesel fuel. The track trial is an extensive trial of 16
trucks that are representative of vehicles operating in the Turkish market. The
vehicles are being driven around the service road of the Formula One track in
Istanbul with fuel usage and mileage recorded and fuel efficiency calculated.


The initial data point of 20,000 km showed positive results of a 1-1.5% fuel
saving, which was in the range of management expectations at that stage of the
trial. The initial trial results from the second data point are currently
inconclusive and it has not been possible to identify whether there has been any
improvement in fuel economy. Further work will be required in order to clarify
the trial results and fully evaluate all aspects of the trial design to
determine whether there are any mitigating factors affecting the trial. Oxonica
continues to review the progress of the trial and subsequent results with Petrol
Ofisi and agree on next steps.


Despite the inconclusive second data point from the trial in Turkey, the Board
believes that there is a large body of evidence to support the view that
ENVIROX(TM) works effectively in a wide-range of operating conditions to reduce
fuel consumption and emissions. Extensive fleet trials in low-sulphur diesel
fuel, which is the predominant form of diesel used throughout Europe, Asia and
the USA have shown fuel savings of 5 - 11%.

Moreover, the Group's other activities in the areas of Healthcare, Security and
Materials continue to make good progress including a key technology development
in Healthcare expected to be announced on April 19th at the AACC Oakridge
Conference in St Louis, a key event for the diagnostics industry, and the
continued adoption of Optisol(TM) UV absorber by the market with it now being
used in 27 formulations, with sales in 9 countries.





For further information, please contact:

Oxonica plc 01865 856 700
Kevin Matthews, Chief Executive
Richard Clarke, Finance Director


The Broadcast PR Business 0207 812 6021
Matthew Locke


Notes to Editors

About Oxonica plc - www.oxonica.com

Oxonica (AIM: OXN.L) is one of the leading International nanomaterials groups
with products already launched into international markets and is listed in
London on the AIM market. It was spun-out from Oxford University in 1999.
Oxonica's mission is to focus on the development of innovative commercial
solutions for international markets using its expertise in the design and
application of nanomaterials. It owns a portfolio of demand driven products that
offer substantial benefits to the target markets of energy, healthcare,
materials and security.

The Group currently has four operating divisions: Oxonica Energy, Oxonica
Healthcare, Oxonica Materials and Oxonica Security. Oxonica has already
launched products into international markets. Lead products include:

* Envirox(TM) Fuel Borne Catalyst - a nanocatalyst improving fuel economy
and reducing emissions
* Optisol(TM) UV Absorber - a revolutionary photostable UV protection system
designed to optimise the performance of quality sunscreens and
anti-premature aging products


Oxonica is also active in searching for the next generation of products and is
already engaged in developing transformational detection technologies which will
enable a new generation of ultrasensitive multiplex diagnostic tools for the
clinical diagnostic life science and security markets. In addition, the company
is developing other UV absorber technologies into polymer systems and coatings,
based on similar technologies to that used in Optisol(TM).




This information is provided by RNS
The company news service from the London Stock Exchange

END
STRDVLBLDXBEBBE

[waldron] 22/3/2007 13:20

Oxonica Holding(s) in Company


RNS Number:5191T
Oxonica plc
22 March 2007




TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES


(1). Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached:

Oxonica plc


2. Reason for the notification (please state Yes/No): ( )

An acquisition or disposal of voting rights: ( )

An acquisition or disposal of financial instruments which may result
in the acquisition of shares already issued to which voting rights are
attached: ( )

An event changing the breakdown of voting rights: ( )

Other (please specify) : ( x )

Initial notification of shareholding

3. Full name of person(s) subject to the notification obligation:

TriVest VCT plc


4. Full name of shareholder(s) (if different from 3.):

As above


5. Date of the transaction and date on which the threshold is crossed or reached
if different):

20 March 2007


6. Date on which issuer notified:


21 March 2007

7. Threshold(s) that is/are crossed or reached:

11%


8. Notified details:





A: Voting rights attached to shares


Class/type of shares Situation previous to
if possible using the the Triggering
ISIN CODE transaction
Number of shares Number of voting Rights

Ordinary Shares
of 1 pence
5,115,947 5,115,947
ISIN:
GB00B0D09P49



Resulting situation after the triggering transaction

Class/type of shares Number of shares Number of voting rights % of voting rights
if possible using
the ISIN CODE
Direct Direct Indirect Direct Indirect

Ordinary Shares
of 1 pence
5,115,947 5,115,947 11.29%
ISIN:
GB00B0D09P49


B: Financial Instruments

Resulting situation after the triggering transaction

Type of Expiration Date Exercise/Conversion Number of voting % of voting
financial Period/ Date rights that may be rights
instrument acquired if the
instrument is
exercised/
converted.

N/A

Total (A+B)
Number of voting rights % of voting rights

5,115,947 11.29%


9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:


N/A


Proxy Voting:


10. Name of the proxy holder:

N/A


11. Number of voting rights proxy holder will cease to hold:

N/A


12. Date on which proxy holder will cease to hold voting rights:

N/A


13. Additional information:

Calculations based on total voting rights of 45,313,338 announced on
28 February 2007.


14. Contact name:

Sarah Penfold


15. Contact telephone number:

020 7925 3323







This information is provided by RNS
The company news service from the London Stock Exchange

END

HOLOKBKNBBKDONB

[matt7777] 20/3/2007 12:02

looks like the accelerated costs are being paid for by the extra sales through Petrol Ofisi - should mean faster + better marketed growth for the Optisol, Nanoplex and now Nano barcoding security business. All paid for by the Turkish operation - where the full rollout / launch is coming in Q2. Other oilco's will be watching this - and wanting to be involved IMO.

On a 2nd read of the statement - the fuel additive testing in the US with the environment agency has moved forward, with "tier 1" now completed. Nothing imminent expected here, though...

[cootuk] 19/3/2007 17:38

I'm a bit disappointed about the "Development, sales and marketing and administration costs" rising so much - they have to grow the business but, whilst I view sales at £10m as excellent, most of that gain has been eaten up by costs.

[waldron] 19/3/2007 15:31

Oxonica "buy"

Monday, March 19, 2007 9:15:53 AM ET
Panmure Gordon & Co

LONDON, March 19 (newratings.com) - Analyst Mark Davis of Panmure Gordon maintains his "buy" rating on Oxonica Plc (ticker: O2Q). The target price is set to 200p.

In a research note published this morning, the analyst mentions that the company has announced encouraging preliminary results for 2006, with revenues ahead of the estimates. The diesel fuel catalyst contributed to a majority of Oxonica's revenues for the year on account of the company's trial with Petrol Ofisi, the analyst says. The company's partnership with Croda, associated with the Optisol UV absorber, is tracking well, Panmure Gordon adds.

[maiseymouse] 19/3/2007 12:23

some reasonably bullish comment from panmure www.market-insider.net

[hyper al] 08/3/2007 07:40

demanko

It says it in back and white, but no timeline is mentioned.

I remember Proteome Sciences (PRM) had a agreement with a US company and investors waited for some 2 years only to be told that trials had failed because of lack understanding by the user!

BD Site

[ariane] 08/3/2007 07:06

Oxonica Notice of Results


RNS Number:5552S
Oxonica plc
08 March 2007


8 March 2007

Oxonica Plc

Notification of New Preliminary Results Date

Oxonica plc, a leading international nanomaterials group, will now announce its
preliminary results for the year ended 31 December 2006 on Monday 19 March
2007, as opposed to Wednesday 21 March 2007.

Kevin Matthews, Chief Executive and Richard Clarke, Chief Financial Officer will
be giving a presentation to analysts at 09.30am at the offices of Smithfield
Consultants, 10 Aldersgate Street, London, EC1A 4HJ.

For further information please contact:

Oxonica Plc www.oxonica.com
Kevin Matthews, Chief Executive Tel. [phone]
Richard Clarke, Finance Director

Smithfield Consultants Tel. [phone]
George Hudson




This information is provided by RNS
The company news service from the London Stock Exchange

END
NORUUUAUWUPMGRM

[hyper al] 07/3/2007 08:17

damanko

I read the RNS, but Nanoplex is not mentioned on the BD website. This concerns me, as I have seen such agreements before and nothing happens. Even worse if they are exclusive agreements, but in this case it is not.